During the month of February, the number of shares and votes in Ascelia Pharma AB have changed due to conversion of a total of 54,500 series C shares into a total of 54,500 ordinary shares for delivery of shares to participants in the performance-based share saving program that was adopted by the annual general meeting held on 14 November 2019 (LTI 2019).
As of 28 February 2023, the number of shares in Ascelia Pharma AB amounts to 34,871,177 shares, of which 33,722,762 are ordinary shares with one vote each and 1,148,415 are series C shares with 1/10 vote each. The total number of votes in the company amounts to 33,837,603.5.